75Indexed trials
Market Rank #45 · Evidence Tier A
Ukraine
Neuroscience Intelligence
Ukraine neuroscience intelligence: 75 indexed trials, 4 institutions, research score 27.65.
13Recruiting
4Research institutions
27.6Research score
Evidence profile
39Sponsors
15Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 27.6 · Data confidence 100.00 · Evidence 27.6
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
epilepsy18trials
parkinsons17trials
multiple_sclerosis9trials
schizophrenia9trials
alzheimers6trials
depression5trials
other_neurology2trials
autism2trials
stroke1trials
bipolar_disorder1trials
Leading indexed sponsors
Merck Sharp & Dohme LLC10trials
Boehringer Ingelheim5trials
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4trials
GlaxoSmithKline3trials
Otsuka Pharmaceutical Development & Commercialization, Inc.3trials
Sumitomo Pharma America, Inc.3trials
Genzyme, a Sanofi Company3trials
Celgene2trials
ACADIA Pharmaceuticals Inc.2trials
Forest Laboratories2trials